Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 66% of retail investor accounts lose money when spread betting and/or trading CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money

71% of retail investor accounts lose money when spread betting and/or trading CFDs with this provider. You should consider whether you can afford to take the high risk of losing your money.

FREE EBOOK

GENOMICS

The Future of Biotechnology: 4 Stocks to Watch

  • A market megatrend
  • Record hedge fund flows
  • Exclusive insider quotes

Includes free newsletter updates, unsubscribe anytime. Privacy policy. This form is protected by reCaptcha

4 things you'll learn

Funds to watch

Discover ETFs tracking cutting-edge CRISPR tech, like the Ark Genomic Revolution ETF that saw $3.03bn inflows in H1 2021.

Rewriting genetic code

These are the stocks revolutionising healthcare by blurring the lines between biology and computer science.

High-growth market

Last year, the global genomics market grew 22.6% faster than its previous three-year average!

Beyond vaccines

Look beyond the headlines, we identify the companies revolutionising DNA editing and cancer detection.

"We are seeing the very first research coming out using [CRISPR tech] in the correction of mutations in models of debilitating genetic diseases like muscular dystrophy."

Angela Bitting, SVP of corporate affairs at Twist Bioscience